Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL.
Lúcio P, Parreira A, van den Beemd MW, van Lochem EG, van Wering ER, Baars E, Porwit-MacDonald A, Bjorklund E, Gaipa G, Biondi A, Orfao A, Janossy G, van Dongen JJ, San Miguel JF. Lúcio P, et al. Among authors: baars e. Leukemia. 1999 Mar;13(3):419-27. doi: 10.1038/sj.leu.2401279. Leukemia. 1999. PMID: 10086733
BIOMED-1 concerted action report: flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL).
Porwit-MacDonald A, Björklund E, Lucio P, van Lochem EG, Mazur J, Parreira A, van den Beemd MW, van Wering ER, Baars E, Gaipa G, Biondi A, Ciudad J, van Dongen JJ, San Miguel JF, Orfao A. Porwit-MacDonald A, et al. Among authors: baars e. Leukemia. 2000 May;14(5):816-25. doi: 10.1038/sj.leu.2401741. Leukemia. 2000. PMID: 10803512
BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted Action Investigation of Minimal Residual Disease in Acute Leukemia: International Standardization and Clinical Evaluation.
Lucio P, Gaipa G, van Lochem EG, van Wering ER, Porwit-MacDonald A, Faria T, Bjorklund E, Biondi A, van den Beemd MW, Baars E, Vidriales B, Parreira A, van Dongen JJ, San Miguel JF, Orfao A; BIOMED-I. Lucio P, et al. Among authors: baars e. Leukemia. 2001 Aug;15(8):1185-92. doi: 10.1038/sj.leu.2402150. Leukemia. 2001. PMID: 11480560
Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease.
van Wering ER, van der Linden-Schrever BE, Szczepański T, Willemse MJ, Baars EA, van Wijngaarde-Schmitz HM, Kamps WA, van Dongen JJ. van Wering ER, et al. Among authors: baars ea. Br J Haematol. 2000 Jul;110(1):139-46. doi: 10.1046/j.1365-2141.2000.02143.x. Br J Haematol. 2000. PMID: 10930991 Free article.
Evaluation of the nation-wide implementation of ALS home monitoring & coaching: an e-health innovation for personalized care for patients with motor neuron disease.
Dontje ML, Kruitwagen-van Reenen E, van Wijk E, Baars E, Visser-Meily JMA, Beelen A; Study Group ALS Home monitoring & Coaching. Dontje ML, et al. Among authors: baars e. BMC Health Serv Res. 2022 Nov 22;22(1):1389. doi: 10.1186/s12913-022-08724-6. BMC Health Serv Res. 2022. PMID: 36419109 Free PMC article.
Anthroposophic Medicinal Products: A Literature Review of Features, Similarities and Differences to Conventional Medicinal Products, Scientific and Regulatory Assessment.
Baars EW, Kienle GS, Heusser P, Pedersen PA, van Wietmarschen HA, Kiene H, von Schoen-Angerer T, Hamre HJ. Baars EW, et al. Glob Adv Health Med. 2022 Mar 8;11:21649561211073079. doi: 10.1177/21649561211073079. eCollection 2022. Glob Adv Health Med. 2022. PMID: 35281956 Free PMC article.
69 results